Use access key #2 to skip to page content.
$36.50 -0.05 (-0.14%)
10/10/2008 4:02 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar kumiawan (73.81) Submitted: 10/09/06 12:10 PM : Outperform Start Price: $57.45 AZN Score: -2.07

recent $4.5 billion in free cash to buy back stock and pay dividends.

Report this Post Replies: 0 | Reply

Featured Broker Partners